Integrated Care for People Who Use Alcohol And/Or Other Drugs

Why It Matters

Integrated care can close treatment gaps for people with co‑occurring substance use and mental health issues, improving outcomes and reducing long‑term health costs. The findings highlight systemic obstacles that, if addressed, could accelerate the UK’s 10‑year drug strategy goals.

Key Takeaways

• Five integration models identified across UK treatment services.
• Progress hindered by short‑term funding and limited incentives.
• Stigma within mental health services remains a major barrier.
• Embedded workers and single‑point access improve referral pathways.
• National guidance and ring‑fenced funding recommended for sustainable integration.

Pulse Analysis

The UK’s 10‑year drug strategy recognises that people who use alcohol or other substances often juggle mental and physical health challenges, yet traditional service delivery keeps these needs siloed. By allocating the Supplementary Substance Misuse Treatment and Recovery Grant, policymakers aimed to catalyse a more cohesive system that links treatment providers with primary care, mental health teams and social services. Early evidence suggests that where integration is intentional—through shared entry points or co‑located staff—patients experience smoother referrals and more holistic support, echoing international best practices in integrated care.

The RAND Europe‑led evaluation, based on 185 interviews and dozens of workshops, mapped five practical models of integration. Single‑point access centres act as a front‑door, directing users to appropriate services, while embedded workers sit within hospitals or community clinics to trigger inward referrals. Joint planned care and leveraging external support further illustrate collaborative pathways, and building in‑house expertise underscores the value of specialised training. However, the study also flags systemic friction: short‑term, unpredictable funding, delayed policy instruments like the Mental Health Joint Action Plan, and persistent stigma within mental health settings all dampen momentum. These barriers create a patchwork of services where success in one locality may not translate elsewhere.

Policymakers and Integrated Care Boards face a clear agenda. Providing ring‑fenced, multi‑year funding can give providers the stability needed to embed integration models fully. National guidance, illustrated with real‑world case studies, would standardise expectations and reduce variability. Moreover, establishing metrics to monitor cross‑service collaboration will enable continuous improvement and accountability. If these steps are taken, the UK could see reduced duplication, better health outcomes for people with co‑occurring disorders, and a more efficient allocation of NHS resources, moving the drug strategy closer to its ambition of a seamless, person‑centred care ecosystem.